Therapy News and Research

RSS

Supermolecules strike blow to cancer cells

Chemistry and biology researchers at Virginia Tech have enhanced the abilities of the molecules they are creating to deliver killing blows to cancer cells. The man-made molecular complexes enter cancer cells and, when signaled, deliver killing medicine or cause the cell to change.

29 Aug 2005

Anti-ageing gene could improve effects of getting old

According to scientists in the United States they have discovered a gene that can keep mice alive for 30% longer than normal.

29 Aug 2005

5-year-old British autistic boy dies after alternative therapy in U.S.

A 5-year-old British autistic boy has died after undergoing a controversial form of alternative therapy.

29 Aug 2005

Long-term hormone therapy used earlier in menopause is associated with fewer wrinkles

Long-term hormone therapy used earlier in menopause is associated with fewer wrinkles and less skin rigidity in postmenopausal women, Yale School of Medicine researchers report in the August issue of Fertility and Sterility.

28 Aug 2005

Continued race and sex disparities heart attack care

Differences based on race and sex in treatment patterns for hospitalized American heart attack patients have remained unchanged over an eight-year period, despite improvements in quality of heart attack care during this time, Emory and Yale School of Medicine researchers write in the August 18 issue of New England Journal of Medicine.

28 Aug 2005

Nitric oxide synthase plays a role in peripheral vascular disease

The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences (PNAS).

26 Aug 2005

New strategy to turn off the function of a special group of T cells to suppress immune response to tumors

A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.

26 Aug 2005

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.

25 Aug 2005

Stem cells with heart bypass surgery trial to begin

The University of Pittsburgh Medical Center (UPMC) has been granted approval by the U.S. Food and Drug Administration (FDA) to conduct a clinical trial to determine the safety and feasibility of injecting a patient's own bone marrow-derived stem cells directly into the heart during conventional heart bypass surgery.

25 Aug 2005

The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter-induced MALT lymphoma

Research led by Dr. Anne Mueller at Stanford University School of Medicine demonstrates that successful eradication of Helicobacter may not prevent future aggressive gastric lymphoma since resting B cells are left behind.

25 Aug 2005

Experimental immunusuppressant drug preserves transplanted kidneys

An international team of transplant physicians has shown that the investigational drug belatacept (LEA29Y) preserves transplanted kidney function as effectively as cyclosporine, the drug most commonly used to prevent the immune system from rejecting transplanted organs.

24 Aug 2005

Immigrant children still mastering the English language risk being shuffled into special education services they don't need

The study showed that the expressive language characteristics of typically developing children learning English as a second language are similar to the English spoken by monolingual children who have specific language impairment.

24 Aug 2005

Depression survey reveals gap in awareness of treatment goals

Results of a new national survey reveal a disparity between what people with depression say they know about their illness and how they manage it.

24 Aug 2005

New drug that selectively blocks immune responses protects kidneys after transplant

In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.

24 Aug 2005

Brain can be tricked into thinking the pain has gone

A new U.S. study has found that it is possible that by just thinking that a medicine will relieve pain is enough to prompt the brain to release its own natural painkillers, and soothe painful sensations.

24 Aug 2005

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).

24 Aug 2005

First direct evidence that endorphins play a role in the phenomenon known as the placebo effect

Just thinking that a medicine will relieve pain is enough to prompt the brain to release its own natural painkillers, and soothe painful sensations, a new University of Michigan study finds.

23 Aug 2005

Study examines the incidence and risk factors associated with Hepatitis C infection in rural Egypt

The prevalence of antibodies to Hepatitis C Virus (HCV) in Egypt is among the highest in the world. From the 1950s until 1982 hundreds of thousands were infected during mass campaigns to control schistosomiasis (a parasitic disease) using mass therapy with intravenous antimony compounds, but little is known about current risk factors and rates of transmission.

23 Aug 2005

Patients with primary biliary cirrhosis who are treated with methotrexate have an increased risk of death

In five randomized controlled trials involving 457 people, the authors report that for patients treated with methotrexate, as a single therapy or in combination with other drug treatment, pooled data showed a tendency toward an increased risk of death or liver transplantation. The brand names for methotrexate are Rheumatrex and Trexall.

23 Aug 2005

Appropriate tests need to be done earlier for ovarian cancer

A new study to be published in the journal CANCER in October has found that many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed.

23 Aug 2005

Therapy News and Research

Supermolecules strike blow to cancer cells

Anti-ageing gene could improve effects of getting old

5-year-old British autistic boy dies after alternative therapy in U.S.

Long-term hormone therapy used earlier in menopause is associated with fewer wrinkles

Continued race and sex disparities heart attack care

Nitric oxide synthase plays a role in peripheral vascular disease

New strategy to turn off the function of a special group of T cells to suppress immune response to tumors

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

Stem cells with heart bypass surgery trial to begin

The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter-induced MALT lymphoma

Experimental immunusuppressant drug preserves transplanted kidneys

Immigrant children still mastering the English language risk being shuffled into special education services they don't need

Depression survey reveals gap in awareness of treatment goals

New drug that selectively blocks immune responses protects kidneys after transplant

Brain can be tricked into thinking the pain has gone

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

First direct evidence that endorphins play a role in the phenomenon known as the placebo effect

Study examines the incidence and risk factors associated with Hepatitis C infection in rural Egypt

Patients with primary biliary cirrhosis who are treated with methotrexate have an increased risk of death

Appropriate tests need to be done earlier for ovarian cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News